Swiss multinational healthcare company Roche has announced that the Food and Drug Administration (FDA) has granted emergency use authorization for the company’s at-home COVID-19 test, The Hill reports.
The test, which uses a nasal swab sample, can produce "accurate, reliable and quick results in as few as 20 minutes," the company said in a statement released on Friday. The test will be available starting in January.
Read more